Pasqal Holding SA announced it would end its participation in a French government quantum computing program, causing its stock to fall 8.36% on September 29, 2026. Following the announcement, Pomerantz LLP launched an investigation into whether Pasqal and its executives engaged in securities fraud or other unlawful practices. Investors affected by the stock drop are encouraged to contact the law firm regarding a potential class action. This development raises concerns about Pasqal's business decisions and potential legal risks ahead.
Pasqal Holding SA's stock fell 8.36% after it announced ending participation in a French quantum computing program, prompting a legal investigation. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 20:41 WIB: out of 150 priced US tech stocks, 19 rose and 129 fell. Notable movers include FTNT at USD 133.37 with a 1-day change of -23.39% and 100% buy order activity, MRVL at USD 219.29 down 12.86%, and IREN at USD 26.32 down 8.74%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
